Zimmer Biomet Holdings Inc (ZBH)
Debt-to-equity ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 5,341,600 | 4,867,900 | 5,152,200 | 5,463,700 | 7,626,500 |
Total stockholders’ equity | US$ in thousands | 12,468,100 | 12,480,500 | 12,020,300 | 12,660,700 | 12,194,200 |
Debt-to-equity ratio | 0.43 | 0.39 | 0.43 | 0.43 | 0.63 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $5,341,600K ÷ $12,468,100K
= 0.43
The debt-to-equity ratio of Zimmer Biomet Holdings Inc has shown a decreasing trend over the past five years, declining from 0.63 on December 31, 2020, to 0.43 as of December 31, 2021, where it remained constant until December 31, 2022. Subsequently, the ratio decreased to 0.39 by December 31, 2023, before rising back to 0.43 by December 31, 2024. This indicates that the company has been effectively managing its debt levels in relation to shareholder equity, which may suggest a more conservative capital structure approach during the period under review.
Peer comparison
Dec 31, 2024
Company name
Symbol
Debt-to-equity ratio
Zimmer Biomet Holdings Inc
ZBH
0.43
Align Technology Inc
ALGN
0.00
Avanos Medical Inc
AVNS
0.00
Edwards Lifesciences Corp
EW
0.09
Intuitive Surgical Inc
ISRG
0.00
MSA Safety
MSA
0.59
STERIS plc
STE
0.50